This page is dedicated to the Intestinal Malrotation and Volvulus research study, one of 57 studies supported by the Boston Children’s Rare Disease Collaborative (CRDC). For more information about the CRDC, please visit our home page. Established in 2018, the CRDC supports pediatric rare disease research and provides families with genetic diagnoses that enable personalized treatments, including precision medicine and targeted therapies.
The Intestinal Malrotation and Volvulus research study, established at Boston Children’s in 2023 and led by Drs. Christopher Duggan, Wen-Hann Tan, Tom Jaksic, and Jonathan Salazar, has already enrolled 20 patients and their families. The study aims to identify genetic causes of intestinal malrotation and provide personalized medicine.